Emmaus Medical
  • CEO Letters
  • Overview
    • Mission
    • Leadership
      • Management Team
      • Board of Directors
    • Corporate Compliance
    • Corporate Governance
  • Products
    • Endari
  • Pipeline
    • Research Publications
    • Diverticulosis
    • Cell Sheet Engineering
  • News
    • Press Releases
    • Media Contacts
    • Media Kit
  • Investors
  • Career
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Pre-merger Emmaus Life Science SEC Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Life Sciences Investor Forum: Company Executives Present Live June 23rd

Jun 21, 2022 9:53pm EDT

Emmaus Life Sciences Reports Q1 2022 Financial Results and Provides Business Update

May 13, 2022 8:23am EDT

Emmaus Life Sciences to Present at Investor Conferences in May

Apr 26, 2022 8:23am EDT

Emmaus Life Sciences Announces Launch of Full-Service Telehealth Solution

Apr 11, 2022 8:23am EDT

Emmaus Life Sciences Presented Positive Real-World Data on the Efficacy of Endari® in Preventing Acute Complications from Sickle Cell Disease at the 62nd Annual Scientific Meeting of the British Society for Haematology

Apr 07, 2022 8:23am EDT

Emmaus Life Sciences Reports 2021 Financial Results and Provides Business Update

Mar 31, 2022 5:24pm EDT

Emmaus Life Sciences Announces Endari® To Be Added to the Florida Medicaid Preferred Drug List

Mar 29, 2022 8:23am EDT

Emmaus Life Sciences Receives U.A.E. Marketing Authorization for Endari®

Mar 23, 2022 8:23am EDT

Emmaus Life Sciences' Real World Data on Endari® Accepted for E-Poster at the 62nd Annual Scientific Meeting of the British Society for Haematology

Mar 04, 2022 8:23am EST

Emmaus Life Sciences to Present at the H.C. Wainwright BioConnect Conference

Jan 04, 2022 8:23am EST
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...14
Next
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Emmaus Medical, Inc. Registered ® Emmaus Medical, Inc, Torrance, CA. All rights reserved.

  • Privacy
  • Terms of Use
  • Contact